This report has been regularly published since 1984 with the latest publication in January 2026, covering historical sales up through 2024. It compiles market data from over 100 countries in units, dollars, prices and market shares by company and by region for each of the therapeutic plasma and recombinant proteins listed below.

• Intravenous and Subcutaneous Immune Globulin (IVIG and SCIG)
• Hyperimmune Globulins: Hepatitis B, Rabies, Rho(D), Tetanus etc.
• Albumin
• Factor VIII and Factor IX (plasma-derived and recombinant, standard & Extended Half-Life along with non -factor hemophilia treatments),
• von Willebrand Factor Complex, Prothrombin Complex and rare coagulation factors
• Activated Prothrombin Complex and recombinant Factor VIIa (Bypassing agents) as well as Hemlibra
• Alpha-1 Antitrypsin
• Antithrombin III
• Fibrinogen, Fibrin Sealant,
• Protein C and other plasma proteins.

The data are broken down by region (Asia & Pacific, Latin America, Europe, Middle East & Africa, and North America) and by company. It provides historical data going back 9 years for an accurate picture of how each product and region has developed over time. The data is cross referenced by company, product and by region for the reader to see the evolution of where products are sold by protein and by company over time.

The report is 208 pages, with over 25 pages of Executive Summary text providing an overview of all the sales of the proteins by region and by company, their individual market landscape trends and some statements and comments about their near term future potential. This is followed by over 100 tables and over 50 charts making up the rest of the document. 

The report is delivered electronically (Excel and pdf files) and costs US $17,500. Individual sections are available for a portion of the total. For more information, please email us at info@marketingresearchbureau.com for any questions.